Team:Goettingen/week18-2

From 2012.igem.org

(Difference between revisions)
Line 589: Line 589:
<br></td></tr>
<br></td></tr>
</table>
</table>
 +
<br>
<br>
 +
<table cellpadding="20 px" border="1" bordercolor="black" valign="top">
<table cellpadding="20 px" border="1" bordercolor="black" valign="top">
<tr bordercolor="black" valign="top">
<tr bordercolor="black" valign="top">
<td width="900" bordercolor="black" valign="top">
<td width="900" bordercolor="black" valign="top">
 +
<h2><b>V08_29 </b></h2><br>
<h2><b>V08_29 </b></h2><br>
-
<b>Ligation and transformation of flhDC-promoter constructs and Psb1c3 </b><br>
+
<b>V08_19_1  Purification of the the <i>flhDC</i>-promoter constructs and pSB1C3 </b><br>
<ul>
<ul>
<li>Experiment: <br>
<li>Experiment: <br>
-
TEXT</li>
+
The restriction product was purified using peqGOLD Gel Extraction Kit (Peqlab) according to the manual.  <br></li>
</ul>
</ul>
-
<br></td></tr>
+
<br>
 +
<b>V08_29_2 Insertion of the <i>flhDC</i>-promoter constructs into pSB1C3</b><br>
 +
<ul>
 +
<li>Experiment:  <br>
 +
The ligation of the digested <i>flhDC</i>-promoter constructs with pSB1C3 was conducted as described in the protocol. <br>
 +
</ul><br>
 +
 
 +
</td></tr>
</table>
</table>
 +
<br>
<br>
<table cellpadding="20 px" border="1" bordercolor="black" valign="top">
<table cellpadding="20 px" border="1" bordercolor="black" valign="top">

Revision as of 11:25, 18 September 2012